Clinical Evidence for Targeted Strategies in Asthma with Type 2 Inflammation: Single and Dual Inhibition

M. Wechsler (Denver, USA)

Source: International Congress 2017 – Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics
Session: Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics
Session type: Evening Symposium
Number: 3084
Disease area: Airway diseases

Webcast

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Wechsler (Denver, USA). Clinical Evidence for Targeted Strategies in Asthma with Type 2 Inflammation: Single and Dual Inhibition. International Congress 2017 – Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019


Characterization of the Immune Response in Clinical Sepsis To Identify Potential Therapeutic Targets
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


Late Breaking Abstract - ACE2 Overexpression Modulates Nicotine Receptors In Cell Type Specific Manner: Possible Relevance In Covid-19
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021



Biology and Role of Type 2 Airway Inflammation
Source: International Congress 2017 – Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics
Year: 2017

A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021



Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

Aerobic Exercise Improves Asthma Phenotype in a Model of Severe Asthma: Involvement of Kinins
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021


Oral presentation: A New Target and Novel Agent to Prevent Acute Lung Injury
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014




Single Cell RNA-seq Reveals Zinc Metabolism Defect of Alveolar Type II Cells with Aging in IPF
Source: ERS Lung Science Conference 2020
Year: 2020

Long-Acting Beta Agonist Asthma Pharmacogenetic Loci Identified in Two Multi-Racial Asthma Clinical Trials
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Type 2 Diabetes Acentuates the Impairment in the Lung Function and Mechanics in Elderly
Source: Virtual Congress 2020 – Advances in lung function practice
Year: 2020


Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019


Right Ventricular Failure in an Animal Model of Severe Pulmonary Arterial Hypertension: eNOS Uncoupling and Protein Kinase G Signaling in the Transition from Adaptive to Maladaptive Remodeling
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005


Applying Modern Molecular Microbiological Techniques to Identify Treatable Chronic Bacterial Airway Infection in Severe Asthma
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




Short Term Multidisciplinary Pulmonary Rehabilitation Is Effective In Early Stage Non Small Cell Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


Simulating the Beneficial Effects of Aerobic Exercise in Asthma in vitro: a way to Understand the Cellular Effects of Exercise in Asthma – Involvement of STAT6
Source: International Congress 2017 – New insights into pathogenesis of lung disease 
Year: 2017

The Effect of Lipid Profile and Obesity on the Grade of Neutropenia in Patients with Small Cell Lung Cancer Treated with Etoposide-Cisplatin as First Regimen.
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019


Late Breaking Abstract - BBT-877, a Potent Autotaxin Inhibitor in Clinical Development to Treat Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019

Responses to Two Different High-Intensity Interval Exercise Training Protocols on Pulmonary Function and Respiratory Muscle Strength In Diabetes Mellitus
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021